Astrantus »

Cme shares owned by Astrantus

Quarter-by-quarter ownership of Cme (CME) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in Cme

Tip: Access up to 7 years of quarterly data

All positions including Cme held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cme by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $381k 1.6k 238.13
2021-12-31 $206k 900 228.89

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding Cme

Vanguard Group
Jpmorgan Chase & Co
Bank of New York Mellon
Parnassus Investments
Norges Bank Investment Management
Guardcap Asset Management
Vontobel Asset Management
T. Rowe Price Associates
Fiera Capital Corporation
Neuberger Berman Group
Henderson Group
Raymond James & Associates
Legal & General Group
Massachusetts Financial Services
Goldman Sachs Group

View all funds holding Cme